OPKO Health Inc (OPK) MAR/2026 Earning Prediction
OPKO Health Inc (OPK) is set to release its MAR/2026 earnings performance on 04/28 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 130.56M and an earnings per share (EPS) of -0.07 for the MAR/2026. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
Earnings Surprise Analysis
OPK Transcript
The earnings call summary reveals a decline in revenue and gross margin, alongside an increased net loss and operating expenses, which are negative indicators. The Q&A session did not provide additional insights or alleviate concerns. The lack of discussion on operational updates, strategic initiatives, and shareholder returns further contributes to uncertainty. Hence, the sentiment is negative, anticipating a stock price decline of -2% to -8% over the next two weeks.
The earnings call highlights a decline in revenue and increased losses, despite some growth in specific segments like the 4Kscore test. The Q&A section reveals uncertainties around key projects and a lack of detailed timelines for critical milestones. Although there's a commitment to shareholder returns through repurchases, the overall financial health and guidance adjustments suggest a negative sentiment, potentially leading to a stock price decrease.
The earnings call presents a mixed picture. Financial performance shows some decline in net income, but there's optimism in product development with potential growth in the 4Kscore product and new collaborations. Market strategy is unclear, with slow market conversion for Pfizer products. Expenses are high, impacting financial health. The shareholder return plan is not explicitly positive or negative. The Q&A reveals uncertainties in efficacy and market conversion. Overall, the rating is neutral due to balanced positives and negatives, with no strong catalysts for significant stock price movement.
The earnings call shows positive developments: a strategic sale to Labcorp, promising product development, and cost reduction initiatives. The Q&A highlights growth in NGENLA prescriptions, 4Kscore test sales, and potential for oxyntomodulin in obesity/MASH treatment. The share repurchase program and cash flow positive guidance further boost sentiment. Despite some management ambiguity, the overall outlook is positive, with optimistic guidance and strategic initiatives likely to drive a stock price increase in the short term.
OPK Report
Frequently Asked Questions
What is the OPKO Health Inc MAR/2026 Earnings Release Date and Time?
OPKO Health Inc (OPK) is scheduled to release its MAR/2026 earnings report on Apr 28, 2026, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
What Are the Consensus Forecasts for OPKO Health Inc MAR/2026 Revenue and EPS?
Analysts' consensus predicts 130.56M in revenue and an EPS of -0.07 for OPKO Health Inc's MAR/2026.
What Does Intellectia's AI Predict for OPKO Health Inc MAR/2026 Earnings?
Intellectia's exclusive AI algorithms forecast a {conclusion} for OPKO Health Inc's MAR/2026 earnings, with a prediction date of Apr 28, 2026. OPKO Health Inc {summary}
How Can I Use This Earnings Prediction to Trade OPK Stock?
Leverage Intellectia's AI forecast to position trades ahead of the Apr 28, 2026 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
How Accurate Is Intellectia's AI for Earnings Predictions Like OPKO Health Inc MAR/2026?
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
How does AI Earnings Prediction generate its forecasts?
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
When are the predictions available, and how often are they updated?
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Can I use AI Earnings Prediction for all types of stocks?
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
